Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT.

Moiseev IS, Tsvetkova T, Aljurf M, Alnounou RM, Bogardt J, Chalandon Y, Drokov MY, Dvirnyk V, Faraci M, Friis LS, Giglio F, Greinix HT, Kornblit BT, Koelper C, Koenecke C, Lewandowski K, Niederwieser D, Passweg JR, Peczynski C, Penack O, Peric Z, Piekarska A, Ronchi PE, Rovo A, Rzepecki P, Scuderi F, Sigrist D, Siitonen SM, Stoelzel F, Sulek K, Tsakiris DA, Wilkowojska U, Duarte RF, Ruutu T, Basak GW.

Bone Marrow Transplant. 2018 Oct 25. doi: 10.1038/s41409-018-0374-3. [Epub ahead of print]

PMID:
30361500
2.

Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Rheumatology (Oxford). 2018 Dec 1;57(12):2200-2212. doi: 10.1093/rheumatology/key242.

PMID:
30107448
3.

Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gül A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Semin Arthritis Rheum. 2019 Feb;48(4):752-762. doi: 10.1016/j.semarthrit.2018.05.008. Epub 2018 May 19.

PMID:
29954598
4.

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.

Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.

PMID:
29625968
5.

Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma.

Morandi F, Barco S, Stigliani S, Croce M, Persico L, Lagazio C, Scuderi F, Belli ML, Montera M, Cangemi G, Pozzi S, Rigo V, Scaruffi P, Amoroso L, Erminio G, Pistoia V, Ferrini S, Corrias MV.

Oncotarget. 2017 May 30;8(32):53194-53209. doi: 10.18632/oncotarget.18285. eCollection 2017 Aug 8.

6.

Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.

Marino M, Scuderi F, Samengo D, Saltelli G, Maiuri MT, Shen C, Mei L, Sabatelli M, Pani G, Antonini G, Evoli A, Bartoccioni E.

PLoS One. 2015 Aug 18;10(8):e0135378. doi: 10.1371/journal.pone.0135378. eCollection 2015.

7.

A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation.

Marino M, Palmieri G, Peruzzi M, Scuderi F, Bartoccioni E.

Mediators Inflamm. 2015;2015:189864. doi: 10.1155/2015/189864. Epub 2015 May 14.

8.

Poly-autoimmunity in patients with myasthenia gravis: A single-center experience.

Evoli A, Caliandro P, Iorio R, Alboini PE, Damato V, LaTorre G, Provenzano C, Marino M, Lauriola L, Scuderi F, Bartoccioni E.

Autoimmunity. 2015;48(6):412-7. doi: 10.3109/08916934.2015.1031890. Epub 2015 Apr 14.

PMID:
25868386
9.

Characterization of B cells in muscle-specific kinase antibody myasthenia gravis.

Guptill JT, Yi JS, Sanders DB, Guidon AC, Juel VC, Massey JM, Howard JF Jr, Scuderi F, Bartoccioni E, Evoli A, Weinhold KJ.

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 26;2(2):e77. doi: 10.1212/NXI.0000000000000077. eCollection 2015 Apr.

10.

A genome-wide association study of myasthenia gravis.

Renton AE, Pliner HA, Provenzano C, Evoli A, Ricciardi R, Nalls MA, Marangi G, Abramzon Y, Arepalli S, Chong S, Hernandez DG, Johnson JO, Bartoccioni E, Scuderi F, Maestri M, Gibbs JR, Errichiello E, Chiò A, Restagno G, Sabatelli M, Macek M, Scholz SW, Corse A, Chaudhry V, Benatar M, Barohn RJ, McVey A, Pasnoor M, Dimachkie MM, Rowin J, Kissel J, Freimer M, Kaminski HJ, Sanders DB, Lipscomb B, Massey JM, Chopra M, Howard JF Jr, Koopman WJ, Nicolle MW, Pascuzzi RM, Pestronk A, Wulf C, Florence J, Blackmore D, Soloway A, Siddiqi Z, Muppidi S, Wolfe G, Richman D, Mezei MM, Jiwa T, Oger J, Drachman DB, Traynor BJ.

JAMA Neurol. 2015 Apr;72(4):396-404. doi: 10.1001/jamaneurol.2014.4103.

11.

T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients.

Marino M, Maiuri MT, Di Sante G, Scuderi F, La Carpia F, Trakas N, Provenzano C, Zisimopoulou P, Ria F, Tzartos SJ, Evoli A, Bartoccioni E.

J Autoimmun. 2014 Aug;52:113-21. doi: 10.1016/j.jaut.2013.12.007. Epub 2014 Jan 4.

PMID:
24397960
12.

Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets.

Marino M, Scuderi F, Ponte E, Maiuri MT, De Cristofaro R, Provenzano C, Rose-John S, Cittadini A, Bartoccioni E.

J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):841-52.

PMID:
24152848
13.

Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis.

Catzola V, Battaglia A, Buzzonetti A, Fossati M, Scuderi F, Fattorossi A, Evoli A.

J Neurol. 2013 Aug;260(8):2163-5. doi: 10.1007/s00415-013-6987-y. Epub 2013 Jun 8. No abstract available.

PMID:
23749295
14.

Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.

Fiorillo C, Brisca G, Cassandrini D, Scapolan S, Astrea G, Valle M, Scuderi F, Trucco F, Natali A, Magnano G, Gazzerro E, Minetti C, Arca M, Santorelli FM, Bruno C.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):241-4. doi: 10.1016/j.bbrc.2012.10.127. Epub 2012 Nov 9.

PMID:
23146629
15.

PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data.

Provenzano C, Ricciardi R, Scuderi F, Maiuri MT, Maestri M, La Carpia F, Sferrazza A, Marino M, Leone L, Lucchi M, Mussi A, Zollino M, Evoli A, Bartoccioni E.

Neuromuscul Disord. 2012 Feb;22(2):131-8. doi: 10.1016/j.nmd.2011.09.003. Epub 2011 Dec 24.

PMID:
22197427
16.

Monosomal complex karyotype in pediatric mixed phenotype acute leukemia.

Tassano E, Tavella E, Micalizzi C, Scuderi F, Cuoco C, Morerio C.

Cancer Genet. 2011 Sep;204(9):507-11. doi: 10.1016/j.cancergen.2011.08.015.

PMID:
22018273
17.

BAFF serum levels in myasthenia gravis: effects of therapy.

Scuderi F, Alboini PE, Bartoccioni E, Evoli A.

J Neurol. 2011 Dec;258(12):2284-5. doi: 10.1007/s00415-011-6092-z. Epub 2011 May 11. No abstract available.

PMID:
21559937
18.

Skeletal muscle cells: from local inflammatory response to active immunity.

Marino M, Scuderi F, Provenzano C, Bartoccioni E.

Gene Ther. 2011 Feb;18(2):109-16. doi: 10.1038/gt.2010.124. Epub 2010 Oct 7. Review.

PMID:
20927136
19.

Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis.

Provenzano C, Marino M, Scuderi F, Evoli A, Bartoccioni E.

J Neuroimmunol. 2010 Jan 25;218(1-2):102-6. doi: 10.1016/j.jneuroim.2009.11.004. Epub 2009 Nov 26.

PMID:
19942297
20.

Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children.

Faraci M, Caviglia I, Morreale G, Lanino E, Cuzzubbo D, Giardino S, Di Marco E, Cirillo C, Scuderi F, Dallorso S, Terranova P, Moroni C, Castagnola E.

Bone Marrow Transplant. 2010 Jun;45(6):1052-5. doi: 10.1038/bmt.2009.302. Epub 2009 Oct 26.

PMID:
19855442
21.

HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5.

Bartoccioni E, Scuderi F, Augugliaro A, Chiatamone Ranieri S, Sauchelli D, Alboino P, Marino M, Evoli A.

Neurology. 2009 Jan 13;72(2):195-7. doi: 10.1212/01.wnl.0000339103.08830.86. No abstract available.

PMID:
19139372
22.

Response to therapy in myasthenia gravis with anti-MuSK antibodies.

Evoli A, Bianchi MR, Riso R, Minicuci GM, Batocchi AP, Servidei S, Scuderi F, Bartoccioni E.

Ann N Y Acad Sci. 2008;1132:76-83. doi: 10.1196/annals.1405.012.

PMID:
18567856
23.

IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts.

Marino M, Scuderi F, Provenzano C, Scheller J, Rose-John S, Bartoccioni E.

J Neuroimmunol. 2008 May 30;196(1-2):41-8. doi: 10.1016/j.jneuroim.2008.02.005. Epub 2008 Apr 8.

PMID:
18400310
24.

Unrelated HSCT in an adolescent affected by congenital erythropoietic porphyria.

Faraci M, Morreale G, Boeri E, Lanino E, Dallorso S, Dini G, Scuderi F, Cohen A, Cappelli B.

Pediatr Transplant. 2008 Feb;12(1):117-20. doi: 10.1111/j.1399-3046.2007.00842.x.

PMID:
18186900
25.

Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma.

Corrias MV, Parodi S, Haupt R, Lacitignola L, Negri F, Sementa AR, Dau D, Scuderi F, Carlini B, Bianchi M, Casale F, Faulkner L, Garaventa A.

Br J Cancer. 2008 Jan 29;98(2):263-9. doi: 10.1038/sj.bjc.6604179. Epub 2008 Jan 8.

26.

A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.

Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, Garrè ML, Moroni C, Conte M, Losurdo G, Scuderi F, Bandettini R, Tomà P, Viscoli C, Haupt R.

Clin Infect Dis. 2007 Nov 15;45(10):1296-304. Epub 2007 Oct 5.

PMID:
17968824
27.

N,N,N-trimethylglycine (betaine) improves analysis of CDR3 diversification in children reconstituting their immune repertoire after hematopoietic stem-cell transplantation.

Terranova MP, Di Michele P, Scuderi F, Valetto A, Di Martino D.

Transplantation. 2007 Apr 15;83(7):996-7. No abstract available. Erratum in: Transplantation. 2007 Sep 27;84(6):802. Martino, Daniela D [corrected to Di Martino, Daniela].

PMID:
17460574
28.

Anti-MuSK antibodies: correlation with myasthenia gravis severity.

Bartoccioni E, Scuderi F, Minicuci GM, Marino M, Ciaraffa F, Evoli A.

Neurology. 2006 Aug 8;67(3):505-7.

PMID:
16894117
29.

Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.

Rostedt Punga A, Ahlqvist K, Bartoccioni E, Scuderi F, Marino M, Suomalainen A, Kalimo H, Stålberg EV.

Clin Neurophysiol. 2006 Jul;117(7):1434-43. Epub 2006 Jun 5.

PMID:
16737845
30.

IL-6-deficient mice show impaired inflammatory response in a model of myosin-induced experimental myositis.

Scuderi F, Mannella F, Marino M, Provenzano C, Bartoccioni E.

J Neuroimmunol. 2006 Jul;176(1-2):9-15. Epub 2006 May 24.

PMID:
16725212
31.

Three consecutive related bone marrow transplants for juvenile myelomonocytic leukaemia.

Faraci M, Micalizzi C, Lanino E, Scuderi F, Morreale G, Dini G, Cappelli B, Dallorso S.

Pediatr Transplant. 2005 Dec;9(6):797-800.

PMID:
16269054
32.

V(H)3 and V(H)6 immunoglobulin M repertoire reconstitution after hematopoietic stem-cell transplantation in children.

Di Martino D, Terranova MP, Scuderi F, Di Michele P, Iacovone S, Scarso L, Dallorso S, Dini G, Morreale G, Valetto A.

Transplantation. 2005 Jan 15;79(1):98-107.

PMID:
15714176
33.

Efficiency of Calamintha officinalis essential oil as preservative in two topical product types.

Nostro A, Cannatelli MA, Morelli I, Musolino AD, Scuderi F, Pizzimenti F, Alonzo V.

J Appl Microbiol. 2004;97(2):395-401.

34.

Identification of disease-specific autoantibodies in seronegative myasthenia gravis.

Bartoccioni E, Marino M, Evoli A, Ruegg MA, Scuderi F, Provenzano C.

Ann N Y Acad Sci. 2003 Sep;998:356-8. No abstract available.

PMID:
14592896
35.

Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.

Brain. 2003 Oct;126(Pt 10):2304-11. Epub 2003 Jun 23.

PMID:
12821509
36.

Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.

Scuderi F, Convertino R, Molino N, Provenzano C, Marino M, Zoli A, Bartoccioni E.

Autoimmunity. 2003 Mar;36(2):71-7.

PMID:
12820688
37.

IL-6, monocyte infiltration and parenchymal cells.

Bartoccioni E, Scuderi F, Marino M, Provenzano C.

Trends Immunol. 2003 Jun;24(6):299-300; author reply 300-1. No abstract available.

PMID:
12810103
38.

TGF-beta 1 and IL-10 modulate IL-1 beta-induced membrane and soluble ICAM-1 in human myoblasts.

Marino M, Scuderi F, Mannella F, Bartoccioni E.

J Neuroimmunol. 2003 Jan;134(1-2):151-7.

PMID:
12507783
39.

Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement.

Scuderi F, Marino M, Colonna L, Mannella F, Evoli A, Provenzano C, Bartoccioni E.

Lab Invest. 2002 Sep;82(9):1139-46.

PMID:
12218074
40.

ACTH, cortisol and prolactin in active rheumatoid arthritis.

Zoli A, Lizzio MM, Ferlisi EM, Massafra V, Mirone L, Barini A, Scuderi F, Bartolozzi F, Magaró M.

Clin Rheumatol. 2002 Aug;21(4):289-93.

PMID:
12189455
41.

Prolactin/cortisol ratio in rheumatoid arthritis.

Zoli A, Ferlisi EM, Lizzio M, Altomonte L, Mirone L, Barini A, Scuderi F, Bartolozzi F, Magaro M.

Ann N Y Acad Sci. 2002 Jun;966:508-12.

PMID:
12114312
42.
43.

Long-term behavior of secretory immunity in ileocecal and ileal orthotopic neobladders.

d'Addessi A, Racioppi M, Fanasca A, Menchinelli P, Alcini A, Delicato G, Alcini E, Scuderi F.

Urol Int. 2001;67(1):41-5.

PMID:
11464114
44.

Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts.

Marino M, Scuderi F, Mazzarelli P, Mannella F, Provenzano C, Bartoccioni E.

J Neuroimmunol. 2001 May 1;116(1):94-101.

PMID:
11311334
45.
46.
47.

Growth factors increase retroviral transduction but decrease clonogenic potential of umbilical cord blood CD34+ cells.

Corrias MV, Scuderi F, Pasino M, Biglino P, Bocca P, Marotta F, Figini E, Pistoia V, Mori PG.

Haematologica. 1998 Jul;83(7):580-6.

48.

Effect of transforming growth factor-beta1 on interleukin-6 secretion in human myoblasts.

Mazzarelli P, Scuderi F, Mistretta G, Provenzano C, Bartoccioni E.

J Neuroimmunol. 1998 Jul 1;87(1-2):185-8.

PMID:
9670861
49.

Myoblasts produce IL-6 in response to inflammatory stimuli.

Gallucci S, Provenzano C, Mazzarelli P, Scuderi F, Bartoccioni E.

Int Immunol. 1998 Mar;10(3):267-73.

PMID:
9576614
50.

Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases.

Manna R, Latteri M, Cristiano G, Todaro L, Scuderi F, Gasbarrini G.

Br J Rheumatol. 1998 Feb;37(2):208-10.

PMID:
9569078

Supplemental Content

Loading ...
Support Center